scispace - formally typeset
Open AccessJournal ArticleDOI

Pathophysiology of Duchenne Muscular Dystrophy: Current Hypotheses

Nicolas Deconinck, +1 more
- 01 Jan 2007 - 
- Vol. 36, Iss: 1, pp 1-7
Reads0
Chats0
TLDR
Because no etiologic therapy is available for Duchenne muscular dystrophy, a better understanding of the primary and downstream mechanisms could prove useful for producing new adjuvant treatments.
About
This article is published in Pediatric Neurology.The article was published on 2007-01-01 and is currently open access. It has received 413 citations till now. The article focuses on the topics: Duchenne muscular dystrophy & Muscular dystrophy.

read more

Citations
More filters
Journal ArticleDOI

Corticosteroids for the treatment of Duchenne muscular dystrophy.

TL;DR: The effects of corticosteroids on prolongation of walking ability, muscle strength, functional ability, and quality of life in DMD are assessed to address the question of whether benefit is maintained over the longer term (more than two years); to assess adverse events.
Journal ArticleDOI

Duchenne muscular dystrophy

TL;DR: The use of corticosteroids, non‐invasive respiratory support, and active surveillance and management of associated complications have improved ambulation, function, quality of life and life expectancy in Duchenne muscular dystrophy.
Journal ArticleDOI

Protein O-mannosylation: conserved from bacteria to humans.

TL;DR: Observations that have opened up the field are summarized and characteristics of O-mannosylation in the different domains/kingdoms of life are highlighted.
Journal ArticleDOI

Mitigation of muscular dystrophy in mice by SERCA overexpression in skeletal muscle

TL;DR: It is shown that the dystrophic phenotype observed in δ-sarcoglycan–null mice and dystrophin mutant mdx mice is dramatically improved by skeletal muscle–specific overexpression of sarcoplasmic reticulum Ca(2+) ATPase 1 (SERCA1).
References
More filters
Journal ArticleDOI

Dystrophin protects the sarcolemma from stresses developed during muscle contraction.

TL;DR: It is demonstrated that dystrophin-deficient muscle fibers of the mdx mouse exhibit an increased susceptibility to contraction-induced sarcolemmal rupture, which strongly support the proposition that the primary function of dyStrophin is to provide mechanical reinforcement to the sarcolemma and thereby protect it from the membrane stresses developed during muscle contraction.
Journal ArticleDOI

Targeted disruption of the neuronal nitric oxide synthase gene

TL;DR: The most evident effect of disrupting the neuronal NOS gene is the development of grossly enlarged stomachs, with hypertrophy of the pyloric sphincter and the circular muscle layer.
Journal ArticleDOI

Nitric oxide in skeletal muscle

TL;DR: It is shown that rat skeletal muscle expresses neuronal-type NO synthase and that activity varies among several respiratory and limb muscles, and that two physiological functions of NO in skeletal muscle are supported.
Journal ArticleDOI

Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy.

TL;DR: In this paper, it was shown that dystrophin complex interacts with an N-terminal domain of nNOS that contains a GLGF motif, which may contribute to preferential degeneration of fast-twitch muscle fibers in Duchenne muscular dystrophy.
Journal ArticleDOI

Calcium Ion in Skeletal Muscle: Its Crucial Role for Muscle Function, Plasticity, and Disease

TL;DR: Functional alterations of Ca(2+) handling seem to be responsible for the pathophysiological conditions seen in dystrophinopathies, Brody's disease, and malignant hyperthermia, which underline the importance of the affected molecules for correct muscle performance.
Related Papers (5)